Craig-Hallum Starts Atossa Genetics (ATOS) at Buy, 'Refining The Gold Standard Therapy For Breast Cancer'
Tweet Send to a Friend
(Updated - June 5, 2025 8:39 AM EDT)
Craig-Hallum analyst Albert Lowe initiates coverage on Atossa Genetics (NASDAQ: ATOS) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Craig-Hallum analyst Albert Lowe initiates coverage on Atossa Genetics (NASDAQ: ATOS) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
